• CMG Pharmaceutical faces delisting unless common shares close at 1,000 won or higher for 45 consecutive trading days within a 90-trading-day period.
• The stock was designated for administrative supervision on Aug. 13, 2026, following 30 consecutive trading days with closing prices below 1,000 won.
• As of Oct. 29, 36 trading days had elapsed since designation; shares had met the price threshold for four consecutive trading days.
• A closing price below 1,000 won from the 46th trading day following designation could trigger delisting under Kosdaq listing rules.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CMG Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030901384), on October 30, 2026, and is solely responsible for the information contained therein.